A clinicopathological and immunohistochemical study of non-urothelial bladder tumours

被引:5
|
作者
Kaur, Sukhpreet [1 ]
Gupta, Avinash [1 ]
Gulwani, Hanni, V [1 ]
机构
[1] Bhopal Mem Hosp & Res Ctr, Dept Pathol, Dept Hlth Res, Bhopal, Madhya Pradesh, India
关键词
Hemangioma; hematuria; leiomyosarcoma; squamous cell; urinary bladder; SQUAMOUS-CELL CARCINOMA; SMOOTH-MUSCLE NEOPLASMS; URINARY-BLADDER; LOCALIZED AMYLOIDOSIS; HEMANGIOMA; LEIOMYOSARCOMA; ADENOCARCINOMA; PARAGANGLIOMA; SURVIVAL; URACHAL;
D O I
10.4103/ijc.IJC_459_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Non-urothelial bladder tumors (NUBTs) are uncommon accounting for approximately 10% of the total urinary bladder tumors while 90% are urothelial in origin. There are very limited comprehensive studies on NUBTs. AIMS AND OBJECTIVES: The objectives of the study were to analyze the clinicopathological and immunohistochemical features of NUBTs. MATERIALS AND METHODS: This is a retrospective study of NUBTs diagnosed over a period of 9 years. Patients' files were retrieved from the archives. Gross and microscopic features were recorded. Simple percentage and frequencies were used to interpret the data. RESULTS: A total 16 cases (10.8% of all bladder tumors) of NUBT were found. Patients' ages ranged from 19 to 87 years with a male: female ratio of 4.3:1. The most common presenting symptom was gross hematuria (81.2%), and the most common location was posterolateral bladder wall. Muscle invasion was seen in 81.2% of cases, and large areas of necrosis were observed in 62.5%. There were two cases of squamous cell carcinoma, five cases each of adenocarcinoma (four secondary and one urachal) and mesenchymal tumors (four malignant and one benign), two cases of amyloid, and one case each of plasmacytomas and paraganglioma. Large areas of necrosis and muscle invasion were noted in high-grade and advanced staged tumors. In all, 43.7% had poor survival. CONCLUSION: NUBTs present with similar clinicoradiological findings; however, their histological features along with immunohistochemistry help in the definite diagnosis. One should be aware of these tumors as they frequently present diagnostic and therapeutic challenge. Most of these neoplasms present at an advanced stage. Large or multicentric randomized controlled studies are needed to know the exact behavior and prognosis of these tumors.
引用
收藏
页码:254 / 260
页数:7
相关论文
共 50 条
  • [21] Urothelial bladder afferent neurons in the rat are anatomically and neurochemically distinct from non-urothelial afferents
    Clodfelder-Miller, Buffie J.
    Kanda, Hirosato
    Gu, Jianguo G.
    Creighton, Judy R.
    Ness, Timothy J.
    DeBerry, Jennifer J.
    BRAIN RESEARCH, 2018, 1689 : 45 - 53
  • [22] Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study
    Epaillard, Nicolas
    Parent, Pauline
    Loriot, Yohann
    Lavaud, Pernelle
    Vera-Cea, E-B
    Martinez-Chanza, Nieves
    Rodriguez-Vida, Alejo
    Dumont, Clement
    Lozano, Rebeca
    Llacer, Casilda
    Ratta, Raffaele
    Oudard, Stephane
    Thibault, Constance
    Auclin, Edouard
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Molecular profiling of non-urothelial bladder cancer: Adenocarcinoma and squamous cell carcinoma
    Geynisman, Daniel M.
    Arguello, David
    Reddy, Sandeep K.
    Gatalica, Zoran
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [24] The clinicopathological and immunohistochemical study of gastrointestinal stromal tumours
    Tepeoglu, M.
    Ozgun, G.
    Ozdemir, B. H.
    VIRCHOWS ARCHIV, 2018, 473 : S175 - S175
  • [25] Clear Cell Variant of Urothelial Carcinoma in Urinary Bladder; a Clinicopathological and Immunohistochemical Study - A Case Report
    Persec, Zoran
    Bukovic, Damir
    Persec, Jasminka
    Rako, Duje
    Ljubanovic, Danica
    Starcevic, Vito
    Zupic, Tomislav
    Pavic, Mato
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 (03) : 1045 - 1047
  • [26] Comparison Between Urothelial and Non-Urothelial Urethral Cancer
    Wenzel, Mike
    Deuker, Marina
    Nocera, Luigi
    Ruvolo, Claudia Colla
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Becker, Andreas
    Kluth, Luis A.
    Chun, Felix K. H.
    Karakiewicz, Pierre, I
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [27] The tumor molecular characteristic and microenvironmental heterogeneity between rare non-urothelial carcinoma of bladder and urothelial carcinoma
    Chen, X.
    Peng, S.
    Chen, Z.
    Zhang, Y.
    Huang, J.
    Lin, T.
    EUROPEAN UROLOGY, 2024, 85 : S1389 - S1389
  • [28] Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer: a systematic review
    Crozier, Jack
    Demkiw, Stephanie
    Lawrentschuk, Nathan
    MINERVA UROLOGICA E NEFROLOGICA, 2016, 68 (02) : 185 - 191
  • [29] Bladder tumor antigen stat test in non-urothelial malignant urologic conditions
    Wald, M
    Halachmi, S
    Amiel, G
    Madjar, S
    Mullerad, M
    Miselevitz, I
    Moskovitz, B
    Nativ, O
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (03): : 174 - 175
  • [30] A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival
    Martin, Jeremy W.
    Jefferson, Francis A.
    Huang, Melissa
    Sung, John M.
    Chang, Jenny
    Piranviseh, Keyhan
    Ziogas, Argyrios
    Anton-Culver, Hoda
    Youssef, Ramy F.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E330 - E336